One of the largest programs of its kind in the world, the Histiocytosis Program at Texas Children’s Cancer Center treats more than 150 new patients each year and follows more than 700 additional patients.
Incorporating a large multidisciplinary team, we treat children and adults with the following histiocytic disorders:
In addition to our team of specialists focused on histiocytosis, patients may see neurologists, radiologists, endocrinologists, orthopaedic surgeons, pathologists, and many other clinical and social specialists in order to receive the best possible care.
With the dramatic growth of the Histiocytosis Program, we have developed and expanded the number of clinical trials of innovative therapies to treat histiocytosis conditions. Our extensive clinical experience, coupled with the basic research studies we design with biopsy and other tissue samples, provides the opportunity for us to establish clinical and biologic correlations that no other center in the world can. Our research focuses on genetic changes in cells of the immune system that lead to LCH and related disorders. We have built a program to discover the causes of these conditions in order to expedite development of more effective and innovative therapies.
The Histiocytosis Program has several active grants from the National Cancer Institute (NCI), the Histiocytosis Association of America (HAA), the American Society of Hematology (ASH) and the American Society for Clinical Oncology (ASCO).
Physicians may make referrals by calling 832-822-4242 or 1-800-226-2379. Families may contact us at 832-822-4240.